Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nonspecific bacterial proteins and lipids in Cutibacterium acnes represent a collective group of molecular targets for broad-spectrum oxidizing agents used in the treatment of acne vulgaris. Unlike targeted antibiotics that bind to specific bacterial structures like the 50S ribosome, agents such as benzoyl peroxide exert their effects by releasing reactive oxygen species (ROS) that induce indiscriminate oxidative damage (Matin & Goodman, 2023 [StatPearls]). This process involves the peroxidation of bacterial membrane lipids and the denaturation of essential cytoplasmic proteins, effectively neutralizing the pathogen without a high risk of developing resistance (Kircik, 2014 [JDD]). In the skin environment, these interactions also help reduce the concentration of free fatty acids and inflammatory mediators produced by C. acnes (Williams et al., 2012 [The Lancet]). The oxidation of these components disrupts the bacterial cell wall and metabolic pathways, leading to a rapid decrease in microbial load within the pilosebaceous unit. Furthermore, the lack of a specific binding site makes it difficult for bacteria to develop genetic resistance, a significant advantage over traditional antibiotic therapies. Consequently, targeting these nonspecific components is a cornerstone of topical acne therapy, providing both bactericidal and anti-inflammatory benefits (Matin & Goodman, 2023 [StatPearls]).
Oxidation of bacterial proteins and lipid peroxidation via reactive oxygen species
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nonspecific bacterial proteins and lipids (Cutibacterium acnes).